Jun 05, 2025
Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
Jun 02, 2025
Trevi Therapeutics Announces Positive Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough
Jun 01, 2025
Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough
May 20, 2025
Trevi Therapeutics Announces Additional Analyses from Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough
May 08, 2025
Trevi Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
May 01, 2025
Trevi Therapeutics to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 8, 2025
Apr 03, 2025
Trevi Therapeutics to Participate in Upcoming April Investor Conferences
Mar 18, 2025
Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates
Feb 27, 2025
Trevi Therapeutics to Participate in Upcoming March Investor Conferences
Jan 30, 2025
Trevi Therapeutics to Participate in Upcoming February Investor Conferences
Jan 08, 2025
Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference
Nov 21, 2024
Trevi Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
Oct 21, 2024
Trevi Therapeutics Completes Enrollment for Phase 2a RIVER Trial in Refractory Chronic Cough
Sep 30, 2024
Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D., as Chief Development Officer
Sep 26, 2024
Trevi Therapeutics Announces Additional Analyses of Cough Relief Time from Ph2a CANAL Trial Accepted for Oral Presentation at CHEST 2024
Sep 04, 2024
Trevi Therapeutics Announces Oral Presentation on Data from Ph2a CANAL Trial at the European Respiratory Society Congress 2024
Aug 28, 2024
Trevi Therapeutics to Participate in September Investor and Medical Conferences
Aug 08, 2024
Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance
Jul 02, 2024
Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events
May 09, 2024
Trevi Therapeutics to Participate in Upcoming Conferences